Presentations we supply
- Injection 200 mg
- Injection 500 mg
- Injection 1 g
- Tablet 50 mg
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for CyclophosphamideReference information
Summarised from the product information for Cyclophosphamide 500 mg powder for solution for injection or infusion (UK product information). Always follow the product information approved in your own country.
- Active substance
- Cyclophosphamide
- Pharmacotherapeutic group
- Antineoplastic agents, alkylating agents, nitrogen mustard analogues (ATC code L01AA01)
- Authorised uses
- Chronic lymphocytic leukaemia
- Acute lymphoblastic leukaemia
- Conditioning before bone marrow transplantation, with whole-body irradiation or busulfan
- Hodgkin lymphoma, non-Hodgkin lymphoma and multiple myeloma
- Metastatic ovarian and breast cancer
- Adjuvant treatment of breast cancer
- Ewing's sarcoma
- Small cell lung cancer
- Advanced or metastatic neuroblastoma
- Severe progressive lupus nephritis and Wegener's granulomatosis
- Storage (unopened)
- Do not store above 25 °C.
- Shelf life (unopened)
- 2 years
- Container and pack
- Clear 50 ml Type I glass vials of 500 mg with bromobutyl stopper and flip-off seal; packs of 1, 5 or 10
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Cyclophosphamide 500 mg powder for solution for injection or infusion: www.medicines.org.uk